Berger, Benjamin http://orcid.org/0000-0001-7777-5734
Brooks, Sander http://orcid.org/0000-0003-3539-2908
Zuiker, Rob http://orcid.org/0000-0001-5604-0157
Richard, Muriel http://orcid.org/0000-0003-0295-7730
Muehlan, Clemens http://orcid.org/0000-0002-0788-3788
Dingemanse, Jasper http://orcid.org/0000-0002-4083-5817
Article History
Accepted: 23 September 2020
First Online: 18 November 2020
Declarations
:
: This study was funded by Idorsia Pharmaceuticals Ltd.
: Benjamin Berger, Muriel Richard, Clemens Muehlan, and Jasper Dingemanse were full-time employees of Idorsia Pharmaceuticals Ltd at the time of study conduct. Muriel Richard, Clemens Muehlan, and Jasper Dingemanse own stocks in Idorsia Pharmaceuticals Ltd, and Clemens Muehlan and Jasper Dingemanse own stock options in Idorsia Pharmaceuticals Ltd. Sander Brooks and Rob Zuiker were employees of CHDR at the time of study conduct. There are no other relationships or activities that could appear to have influenced the submitted work. CHDR received financial compensation for conducting the study from Idorsia Pharmaceuticals Ltd.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study prior to any study-mandated procedure.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: MR and JD designed the study. BB and SB wrote the manuscript. SB and RZ performed the assessments and collected the data. Data were analyzed by BB, CM, SB, and RZ. All authors reviewed and approved the final manuscript.